Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Schedule of Outstanding Shares of Common Stock Equivalents Excluded from Calculation (Details)

v3.22.1
Summary of Significant Accounting Policies - Schedule of Outstanding Shares of Common Stock Equivalents Excluded from Calculation (Details) - shares
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Stock Options    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive excluded from the calculation of diluted loss per common share (in shares) 34,365,000 21,560,000
Common shares underlying convertible debt    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive excluded from the calculation of diluted loss per common share (in shares) 5,124,384 5,124,384
Warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive excluded from the calculation of diluted loss per common share (in shares) 134,187,225 78,546,668
Unvested restricted stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive excluded from the calculation of diluted loss per common share (in shares) 4,000,000 0